-+ 0.00%
-+ 0.00%
-+ 0.00%

*PMV Pharmaceuticals: Cash, Cash Equivalents, and Marketable Securities of $93.5M as of March 31 Providing Expected Cash Runway to End of 2Q of 2027 >PMVP

Dow Jones·05/12/2026 12:02:00

Please log in to view news